New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 21, 2014
06:02 EDTAFFXAffymetrix receives clearance to market CytoScan Dx Assay
Affymetrix announced that it has received 510k clearance from the FDA to market its CytoScan Dx Assay. This assay is intended for the postnatal detection of DNA copy number variants in patients referred for chromosomal testing. CytoScan Dx Assay is designed to help physicians diagnose children’s developmental and intellectual disabilities more comprehensively by enabling a high-resolution genome-wide analysis of genetic aberrations. High resolution analysis can reveal small aberrations not readily seen using traditional techniques.
News For AFFX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 30, 2014
16:01 EDTAFFXAffymetrix reports Q3 EPS 8c, consensus 4c
Subscribe for More Information
October 20, 2014
07:10 EDTAFFXAmerican Society of Human Genetics to hold annual meeting
Subscribe for More Information
06:32 EDTAFFXAffymetrix licenses Peptide Groove technology
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use